Company profile: Benevolent
1.1 - Company Overview
Company description
- Provider of AI-enabled drug discovery and development solutions, including the Benevolent Platform integrating diverse biomedical data; end-to-end drug discovery services from target identification to clinical development; customizable SaaS tools (BenAI-Q, BenAI Research Assistant); a preclinical and clinical pipeline (lead asset for ulcerative colitis); biopharma partnerships; and a data diversity initiative.
Products and services
- Preclinical & Clinical Development Pipeline: A clinical-stage pipeline advancing high-potential assets through preclinical and clinical development, including a lead drug candidate for ulcerative colitis
- Benevolent Platform: An AI-enabled drug discovery engine that integrates diverse biomedical data to accelerate scientific advances across all diseases and support collaborations with biopharma companies to discover novel treatments
- End-to-End Drug Discovery: Integrated end-to-end drug discovery services covering the entire process from target identification to clinical development, leveraging the AI platform, scientific expertise, and wet-lab facilities
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Benevolent
CRIO
HQ: United States
Website
- Description: Provider of eSource technology and tools to streamline clinical research workflows, including a web-based system for direct data capture with real-time entry and monitoring, and Reviewer EDC, an interface integrating eSource with Electronic Data Capture to enable remote monitoring and data review.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CRIO company profile →
Geospiza
HQ: United States
Website
- Description: Provider of software systems for workflow management of genetic analysis, offering GeneSifter Analysis Edition, a cloud-based data analysis product for microarray and sequencing data, and GeneSifter Lab Edition, a software platform supporting laboratory workflows.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Geospiza company profile →
Smart-Trial
HQ: Denmark
Website
- Description: Provider of a global SaaS platform for clinical data management for medical devices, designed to collect and manage data throughout the medical device lifecycle, helping manufacturers illustrate device quality and safety by improving data collection and management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Smart-Trial company profile →
Cypher Genomics
HQ: United States
Website
- Description: Provider of automated human genome interpretation software for next-generation sequencing, supporting diagnostics development and biomarker analysis for clinical labs, pharmaceutical companies, and population genomics efforts; offers the Mantis Genomic Coral Biomarker Array Chip, qPCR Assay, and miscellaneous diagnostic ELISA kits. Platform allows clinical labs to tune sensitivity and specificity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cypher Genomics company profile →
CTS Database
HQ: United States
Website
- Description: Provider of a clinical trial subject registry that preserves the privacy and security of research subjects while providing sponsors and investigators with crucial information.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CTS Database company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Benevolent
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Benevolent
2.2 - Growth funds investing in similar companies to Benevolent
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Benevolent
4.2 - Public trading comparable groups for Benevolent
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →